Patients with SMAC-positive superficial BC had a longer RFS than those with lower SMAC expression after TURBT (p<0.05) and disease-specific survival of patients with invasive BC after radical cystectomy correlated positively with SMAC expression (p<0.05). Here, DIABLO is linked to breast cancer.